Adagene Inc
NASDAQ:ADAG

Watchlist Manager
Adagene Inc Logo
Adagene Inc
NASDAQ:ADAG
Watchlist
Price: 1.91 USD -4.02% Market Closed
Market Cap: 90m USD

Wall Street
Price Targets

ADAG Price Targets Summary
Adagene Inc

Wall Street analysts forecast ADAG stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ADAG is 10.31 USD with a low forecast of 3.54 USD and a high forecast of 19.75 USD.

Lowest
Price Target
3.54 USD
85% Upside
Average
Price Target
10.31 USD
440% Upside
Highest
Price Target
19.75 USD
934% Upside
Adagene Inc Competitors:
Price Targets
214450
PharmaResearch Co Ltd
13% Downside
RYTM
Rhythm Pharmaceuticals Inc
28% Upside
MRNA
Moderna Inc
70% Upside
LEGN
Legend Biotech Corp
124% Upside
PRQR
ProQR Therapeutics NV
402% Upside
ACAD
ACADIA Pharmaceuticals Inc
22% Upside
IMNM
Immunome Inc
170% Upside
600201
Jinyu Bio-Technology Co Ltd
10% Upside

Revenue
Forecast

Revenue Estimate
Adagene Inc

For the last 5 years the compound annual growth rate for Adagene Inc's revenue is -26%. The projected CAGR for the next 3 years is 255%.

-26%
Past Growth
255%
Estimated Growth
Estimates Accuracy
-9%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Adagene Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Net Income
Forecast

Net Income Estimate
Adagene Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ADAG's stock price target?
Price Target
10.31 USD

According to Wall Street analysts, the average 1-year price target for ADAG is 10.31 USD with a low forecast of 3.54 USD and a high forecast of 19.75 USD.

What is Adagene Inc's Revenue forecast?
Projected CAGR
255%

For the last 5 years the compound annual growth rate for Adagene Inc's revenue is -26%. The projected CAGR for the next 3 years is 255%.

Back to Top